Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Gross Margin (2017 - 2025)

Creative Medical Technology Holdings has reported Gross Margin over the past 9 years, most recently at 66.87% for Q4 2025.

  • Quarterly Gross Margin rose 687.0% to 66.87% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 63.43% through Dec 2025, up 343.0% year-over-year, with the annual reading at 63.43% for FY2025, 343.0% up from the prior year.
  • Gross Margin was 66.87% for Q4 2025 at Creative Medical Technology Holdings, up from 60.0% in the prior quarter.
  • Over five years, Gross Margin peaked at 70.91% in Q3 2022 and troughed at 41.78% in Q4 2021.
  • The 5-year median for Gross Margin is 60.0% (2021), against an average of 59.89%.
  • Biggest five-year swings in Gross Margin: tumbled -1714bps in 2021 and later skyrocketed 2758bps in 2022.
  • Tracing CELZ's Gross Margin over 5 years: stood at 41.78% in 2021, then soared by 66bps to 69.35% in 2022, then fell by -13bps to 60.0% in 2023, then changed by 0bps to 60.0% in 2024, then grew by 11bps to 66.87% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 66.87%, 60.0%, and 60.0% for Q4 2025, Q1 2025, and Q4 2024 respectively.